Lymph node (LN) retrieval as a high-risk factor in stage II and III colon cancer

被引：0
作者：
Kim, Y. T. [1 ]
Kim, H. S. [2 ]
Shin, S. J. [2 ]
Beom, S-H. [2 ]
Kim, N. K. [3 ]
Lee, K. Y. [3 ]
Min, B. S. [3 ]
Hur, H. [3 ]
Cho, M. S. [3 ]
Han, Y. D. [3 ]
Yang, S. Y. [3 ]
Koom, W. S. [4 ]
Chang, J. S. [4 ]
Kim, T. I. [5 ]
Cheon, J. H. [5 ]
Park, S. J. [5 ]
Park, J. J. [5 ]
Seo, N. E. [6 ]
Lim, J. S. [6 ]
Ahn, J. B. [2 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea
[2] Yonsei Univ, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr, Seoul, South Korea
[3] Yonsei Univ, Dept Surg, Yonsei Canc Ctr, Seoul, South Korea
[4] Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul, South Korea
[5] Yonsei Univ, Yonsei Canc Ctr, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea
[6] Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.528
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
417P
引用
收藏
页码：S418 / S419
页数：2
相关论文
共 50 条
  • [21] Biomarker for high-risk patients with stage II colon cancer
    Watanabe, Toshiaki
    LANCET ONCOLOGY, 2013, 14 (13) : 1247 - 1248
  • [22] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [23] A MICROSIMULATION MODEL FOR HIGH-RISK STAGE II AND STAGE III COLON CANCER SURVIVORS FOLLOWING THE CURRENT GUIDELINES
    Samur, S.
    Gursel, E.
    Gu, N. Y.
    Palomares, M.
    Sahinkoc, M.
    Hoban, O.
    Cuyun, Carter G.
    Ayer, T.
    Chhatwal, J.
    Parikh, A.
    Neugut, A., I
    VALUE IN HEALTH, 2024, 27 (06) : S14 - S14
  • [24] Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer
    Law, CHL
    Wright, FC
    Rapanos, T
    Alzahrani, M
    Hanna, SS
    Khalifa, M
    Smith, AJ
    JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (03) : 120 - 126
  • [25] Identification of Risk Factors for Recurrence in High-Risk Stage II Colon Cancer
    Hatano, Satoshi
    Ishida, Hideyuki
    Ishibashi, Keiichiro
    Kumamoto, Kensuke
    Haga, Norihiro
    Miura, Ichiro
    INTERNATIONAL SURGERY, 2013, 98 (02) : 114 - 121
  • [26] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [27] High-Risk Stage II Colon Cancer After Curative Resection
    Sato, Harunobu
    Maeda, Koutarou
    Sugihara, Kenichi
    Mochizuki, Hidetaka
    Kotake, Kenjiro
    Teramoto, Tetsuo
    Kameoka, Shingo
    Saito, Yukio
    Takahashi, Keiichi
    Hirai, Takashi
    Ohue, Masayuki
    Shirouzu, Kazuo
    Sakai, Yoshiharu
    Watanabe, Toshiaki
    Hirata, Koichi
    Hatakeyama, Katsuyoshi
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (01) : 45 - 52
  • [28] Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
    Hu, Huabin
    Wu, Zehua
    Wang, Chao
    Huang, Yan
    Zhang, Jianwei
    Cai, Yue
    Xie, Xiaoyu
    Li, Jianxia
    Shen, Cailu
    Li, Weiwei
    Ling, Jiayu
    Xu, Xuehu
    Deng, Yanhong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [30] Association of NCCN guideline adherence with improved survival in high-risk stage II and stage III colon cancer.
    Boland, Genevieve Marie
    Chiang, Yj
    Chagpar, Ryaz
    Xing, Yan
    Hu, Chung-Yuan
    Feig, Barry W.
    Chang, George J.
    You, Y. Nancy
    Cormier, Janice N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345